What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
His primary areas of study are Biochemistry, Gene, Transcriptome, Computational biology and Gene expression.
His Gene research includes elements of Molecular biology and Carcinogen.
His Carcinogen research is multidisciplinary, incorporating elements of Carcinogenesis and Genotoxicity.
Jos C. S. Kleinjans combines subjects such as DNA microarray, In vitro and Metabolomics with his study of Transcriptome.
His Computational biology research includes elements of Toxicogenomics and Bioinformatics.
His Gene expression research is within the category of Genetics.
His most cited work include:
- A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium (640 citations)
- Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 (416 citations)
- Toward interoperable bioscience data (299 citations)
What are the main themes of his work throughout his whole career to date?
Jos C. S. Kleinjans mainly investigates Transcriptome, Carcinogen, Gene expression, Gene and Computational biology.
His Transcriptome research integrates issues from In vitro, Bioinformatics, Gene expression profiling, Cell biology and Toxicogenomics.
His research in In vitro intersects with topics in Toxicity, Molecular biology and Pharmacology.
The Carcinogen study combines topics in areas such as Carcinogenesis, DNA damage and Genotoxicity.
The various areas that Jos C. S. Kleinjans examines in his Gene expression study include Cancer research, microRNA and Physiology.
His study on Gene is covered under Genetics.
He most often published in these fields:
- Transcriptome (22.07%)
- Carcinogen (15.80%)
- Gene expression (15.53%)
What were the highlights of his more recent work (between 2015-2021)?
- Transcriptome (22.07%)
- Gene (15.26%)
- Gene expression (15.53%)
In recent papers he was focusing on the following fields of study:
Jos C. S. Kleinjans focuses on Transcriptome, Gene, Gene expression, DNA methylation and Bioinformatics.
His Transcriptome research incorporates themes from In vitro, Immunology, Microarray, Disease and Physiology.
Gene is a subfield of Genetics that he explores.
His DNA methylation research is multidisciplinary, relying on both Methylation, Carcinogenesis, Cell biology, Epigenetics and Pharmacology.
His work deals with themes such as Inflammation, Colorectal cancer and Gene expression profiling, which intersect with Bioinformatics.
His research integrates issues of DNA microarray and Carcinogen in his study of Toxicogenomics.
Between 2015 and 2021, his most popular works were:
- The exposome in practice: Design of the EXPOsOMICS project. (130 citations)
- Transcriptomic and metabolomic data integration (91 citations)
- From the exposome to mechanistic understanding of chemical-induced adverse effects (82 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Jos C. S. Kleinjans spends much of his time researching Transcriptome, DNA methylation, Bioinformatics, Gene expression profiling and Disease.
The Transcriptome portion of his research involves studies in Gene, Gene expression and Genetics.
The study incorporates disciplines such as Molecular biology and Comet assay in addition to Gene.
His Genetics study combines topics in areas such as Blood sampling and Toxicology.
His biological study spans a wide range of topics, including Methylation, Pathogenesis, Carcinogenesis, Epigenetics and Pharmacology.
His Gene expression profiling research is multidisciplinary, incorporating elements of Hepatitis B, Genome-wide association study, Visualization, Regulation of gene expression and Drug treatment.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
